Allergy and Immunology, Allergy · Sacramento, CA
NPI
1073524740
Since 2006
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
5609 J Street, Suite C
Sacramento, CA, 95819
Phone (916) 453-8696
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
41,164 services
Medicare patients, 2024
495
Average age 75
Drug cost, 2024
$3.1M
4,672 prescriptions
Company payments, 2025
$48K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bradley E Chipps was code J2356 (injection, tezepelumab-ekko, 1 mg), 15,960 times for 13 patients. In total Bradley E Chipps billed 41,164 services in 33 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2356 Injection, tezepelumab-ekko, 1 mg | Office | 15,960 | 13 | $14.21 | $227K |
| J2357 Injection, omalizumab, 5 mg | Office | 12,030 | 24 | $29.77 | $358K |
| 95165 Treatment - Miscellaneous | Office | 3,474 | 63 | $12.96 | $45K |
| J0517 Injection, benralizumab, 1 mg | Office | 2,700 | 19 | $130.86 | $353K |
| 95117 Treatment - Miscellaneous | Office | 2,062 | 159 | $9.57 | $20K |
| 95144 Treatment - Miscellaneous | Office | 1,693 | 75 | $12.95 | $22K |
| 95004 Test - Miscellaneous | Office | 1,065 | 24 | $3.11 | $3,311 |
| 99214 Office E&M - Established | Office | 704 | 353 | $102.86 | $72K |
| 96372 Injection Administration | Office | 686 | 63 | $11.88 | $8,152 |
| 94010 Pulmonary Function Testing | Office | 198 | 169 | $23.27 | $4,607 |
| 96160 E&M - Miscellaneous | Office | 192 | 145 | $2.70 | $518 |
| 95115 Treatment - Miscellaneous | Office | 104 | 12 | $8.28 | $861 |
| 99213 Office E&M - Established | Office | 71 | 62 | $57.98 | $4,117 |
| 95012 Pulmonary | Office | 63 | 54 | $16.95 | $1,068 |
| 99204 Office E&M - New | Office | 39 | 39 | $129.97 | $5,069 |
By year: 2022 $2.1M for 81,549 services; 2023 $1.6M for 62,351 services; 2024 $1.1M for 41,164 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bradley E Chipps prescribed most often to Medicare patients was Montelukast Sodium, with 493 prescriptions and refills. In total Bradley E Chipps wrote 4,672 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 493 | 1,175 | 131 | $7,374 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 397 | 518 | 164 | $16K |
| Azithromycin Generic | 244 | 445 | 87 | $6,455 |
| Symbicort Budesonide/Formoterol Fumarate | 228 | 391 | 71 | $90K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 212 | 316 | 50 | $191K |
| Breo Ellipta Fluticasone/Vilanterol | 207 | 348 | 58 | $133K |
| Dupixent Syringe Dupilumab | 182 | 182 | 19 | $678K |
| Fluticasone Propionate Generic | 181 | 322 | 59 | $3,165 |
| Azelastine Hcl Generic | 168 | 346 | 73 | $7,745 |
| Spiriva Respimat Tiotropium Bromide | 162 | 281 | 41 | $136K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 157 | 204 | 35 | $127K |
| Azelastine-Fluticasone Azelastine/Fluticasone | 145 | 237 | 45 | $24K |
| Xolair Omalizumab | 139 | 139 | 16 | $392K |
| Breyna Budesonide/Formoterol Fumarate | 95 | 137 | 33 | $19K |
| Epinephrine Generic | 76 | 90 | 53 | $21K |
Brand drugs: 2,569 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bradley E Chipps $48K ($48K in general payments such as food, travel and fees) from 14 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $25K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 49 | $25K |
| Genzyme Corporation SNY | 20 | $21K |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $2,209 |
| Genentech USA, Inc. ROG.SW | 2 | $183 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 4 | $118 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $83.3 |
| Amgen Inc. AMGN | 4 | $79.81 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $65.44 |
| Inspire Medical Systems, Inc. INSP | 1 | $48.94 |
| Ionis Pharmaceuticals, Inc. IONS | 1 | $31.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.